Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 2
2010 2
2011 6
2013 2
2014 1
2015 2
2016 3
2017 4
2018 7
2019 11
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib.
Gángó A, Alpár D, Galik B, Marosvári D, Kiss R, Fésüs V, Aczél D, Eyüpoglu E, Nagy N, Nagy Á, Krizsán S, Reiniger L, Farkas P, Kozma A, Ádám E, Tasnády S, Réti M, Matolcsy A, Gyenesei A, Mátrai Z, Bödör C. Gángó A, et al. Among authors: reiniger l. Int J Cancer. 2020 Jan 1;146(1):85-93. doi: 10.1002/ijc.32502. Epub 2019 Jun 25. Int J Cancer. 2020. PMID: 31180577
[The genetic landscape of chronic lymphocytic leukemia].
Marosvári D, Alpár D, Király AP, Rajnai H, Reiniger L, Bödör C. Marosvári D, et al. Among authors: reiniger l. Magy Onkol. 2016 Jun 6;60(2):118-25. Epub 2016 Feb 6. Magy Onkol. 2016. PMID: 27275638 Free article. Review. Hungarian.
Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.
Bödör C, Reiniger L. Bödör C, et al. Among authors: reiniger l. Cancer Metastasis Rev. 2016 Mar;35(1):109-27. doi: 10.1007/s10555-016-9608-2. Cancer Metastasis Rev. 2016. PMID: 26957091 Review.
Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution.
Asa SL, Asioli S, Bozkurt S, Casar-Borota O, Chinezu L, Comunoglu N, Cossu G, Cusimano M, Delgrange E, Earls P, Ezzat S, Gazioglu N, Grossman A, Guaraldi F, Hickman RA, Ikeda H, Jaffrain-Rea ML, Karavitaki N, Kraljević I, La Rosa S, Manojlović-Gačić E, Maartens N, McCutcheon IE, Messerer M, Mete O, Nishioka H, Oz B, Pakbaz S, Pekmezci M, Perry A, Reiniger L, Roncaroli F, Saeger W, Söylemezoğlu F, Tachibana O, Trouillas J, Turchini J, Uccella S, Villa C, Yamada S, Yarman S. Asa SL, et al. Among authors: reiniger l. Pituitary. 2020 Jun;23(3):322-325. doi: 10.1007/s11102-019-01015-0. Pituitary. 2020. PMID: 31834538 No abstract available.
Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
Bödör C, Alpár D, Marosvári D, Galik B, Rajnai H, Bátai B, Nagy Á, Kajtár B, Burján A, Deák B, Schneider T, Alizadeh H, Matolcsy A, Brandner S, Storhoff J, Chen N, Liu M, Ghali N, Csala I, Bagó AG, Gyenesei A, Reiniger L. Bödör C, et al. Among authors: reiniger l. J Neuropathol Exp Neurol. 2020 Feb 1;79(2):176-183. doi: 10.1093/jnen/nlz125. J Neuropathol Exp Neurol. 2020. PMID: 31886867
[Possibilities of immune checkpoint inhibitor therapy for patients with metastatic non-small cell lung cancer].
Téglási V, Moldvay J, Szállási Z, Reiniger L. Téglási V, et al. Among authors: reiniger l. Magy Onkol. 2019 Sep 18;63(3):233-238. Epub 2019 Jul 26. Magy Onkol. 2019. PMID: 31533144 Free article. Review. Hungarian.
Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.
Krokker L, Nyírő G, Reiniger L, Darvasi O, Szücs N, Czirják S, Tóth M, Igaz P, Patócs A, Butz H. Krokker L, et al. Among authors: reiniger l. Neurochem Res. 2019 Oct;44(10):2360-2371. doi: 10.1007/s11064-019-02789-2. Epub 2019 Apr 3. Neurochem Res. 2019. PMID: 30945144 Free PMC article.
[Aspects of nutrition therapy of an infant with central nervous system tumour].
Györke E, Vargáné Németh A, Balogh M, Masát P, Benyó G, Reiniger L, Nagy G, Hauser P. Györke E, et al. Among authors: reiniger l. Magy Onkol. 2018 Dec 12;62(4):237-241. Epub 2018 Nov 22. Magy Onkol. 2018. PMID: 30540866 Free article. Review. Hungarian.
EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
Szurián K, Csala I, Marosvári D, Rajnai H, Dezső K, Bödör C, Piurkó V, Matolcsy A, Reiniger L. Szurián K, et al. Among authors: reiniger l. Exp Mol Pathol. 2018 Oct;105(2):161-165. doi: 10.1016/j.yexmp.2018.07.009. Epub 2018 Jul 18. Exp Mol Pathol. 2018. PMID: 30031020
Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas.
Németh K, Szücs N, Czirják S, Reiniger L, Szabó B, Barna G, Karászi K, Igaz P, Zivkovic V, Korbonits M, Patócs A, Butz H. Németh K, et al. Among authors: reiniger l. Oncotarget. 2018 Jun 26;9(49):29180-29192. doi: 10.18632/oncotarget.25650. eCollection 2018 Jun 26. Oncotarget. 2018. PMID: 30018744 Free PMC article.
45 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback